Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 424B3 Offering Prospectus
  2. DEFR14A Other DEFR14A
  3. DEF 14A Proxy Proxy Statement
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1/A Offering Registration Statement
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. 8-K Event Results of operations
  9. 10-K Report Annual Report
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. D Other Notice of Sales of Unregistered Securities
  13. 4 Insider Changes in Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Insider Changes in Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. CT ORDER Other Confidential Order
  19. D Other Notice of Sales of Unregistered Securities
  20. UPLOAD Other SEC-generated Letter

Page 49 of 72 · 1,429 filings